News

BioWorld: Fluorination Propels SciFluor into 'Billion-Dollar' Markets

26-Oct-2012

Fluorination Propels SciFluor Into ‘Billion-Dollar’ Markets 
By Marie Powers Staff Writer 

Nearly one in four marketed drugs contains the chemical element fluorine, including household names for vastly different indications such as Lipitor (atorvastatin, Pfizer Inc.), Cipro (ciprofloxacin, Bayer AG) and Prozac (fluoxetine, Eli Lilly and Co.) The reason? The carbon-fluorine bond, the strongest in organic chemistry, is widely used to block sites of metabolism and improve drug half-life. Using fluorine to modify the chemical structure of a drug has been demonstrated to improve potency, selectivity, tissue penetration, half-life and metabolic stability.

To read further please visit via subscription:

 

The Latest Press

24-Jan-2015

How a New Coating Could Enable Tinier Electronics in the Body

Biotectix (Ann Arbor, MI), has found a more durable way to enhance electrodes with conductive polymer coatings. The development could further enable the miniaturization of imp..

11-Jan-2015

Federated Wireless Names Wireless Industry Veteran Kurt Schaubach as Chief Technology Officer

Federated Wireless Names Wireless Industry Veteran Kurt Schaubach as Chief Technology Officer Boston (January 13, 2015) – Federated Wireless, which develops tech..

07-Jan-2015

SciFluor Life Sciences Awarded U.S. Patent for KCNQ2/3 Activator Designed for Treatment of Epilepsy

SciFluor Life Sciences Awarded U.S. Patent for KCNQ2/3 Activator Designed for Treatment of Epilepsy and Related Neurological Disorders • Patent-protected neuronal p..